Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells

Journal of the National Cancer Institute

Volumn 92, Issue 8, 2000, Pages 628-635

  Corcione, Anna ^a   Ottonello, Luciano ^b   Tortolina, Giuseppe ^b   Facchetti, Paola ^a   Airoldi, Irma ^a   Guglielmino, Roberta ^a   Dadati, Patrizia ^c   Truini, Mauro ^c   Sozzani, Silvano ^d   Dallegri, Franco ^b   Pistoia, Vito ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; MESSENGER RNA; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL MIGRATION; CHEMOTAXIS; CLINICAL ARTICLE; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL;

EID: 18744419940     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.8.628     Document Type: Article

References (59)

1. Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-35.
2. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998;16: 2780-95.
3. Jaffe E, Shevach EM, Frank MM, Berard CW, Green I. Nodular lymphoma - evidence for origin from follicular B lymphocytes. N Engl J Med 1974;290:813-9.
4. Warnke R, Levy R. Immunopathology of follicular lymphoma. A model of B-lymphocyte homing. N Engl J Med 1978;298:481-6.
5. Stein H, Gerdes J, Mason DY. The normal and malignant germinal centre. Clin Haematol 1982;11:531-59.
6. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A Revised European-American Classification of Lymphoid Neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84: 1361-92.
7. Frizzera G, Murphy SB. Follicular (nodular) lymphoma in childhood: a rare clinical-pathological entity. Report of eight cases from four cancer centers. Cancer 1979;44:2218-35.
8. Wright DH, Isaacson P. Follicular center cell lymphoma of childhood: a report of three cases and a discussion of its relationship to Burkitt's lymphoma. Cancer 1981;47:915-25.
9. Pinto A, Hutchison RE, Grant LH, Trevenen CL, Berard CW. Follicular lymphomas in pediatric patients. Mod Pathol 1990;3:308-13.
10. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 1984;311:1471-5.
11. Horning SJ. Natural history of and therapy for the indolent non-Hodgkin's lymphomas. Semin Oncol 1993;20(5 Suppl 5):75-88.
12. Hollema H, Poppema S. Immimophenotypes of malignant lymphoma centroblastic-centrocytic and malignant lymphoma centrocytic: an immunohistologic study indicating a derivation from different stages of B cell differentiation. Hum Pathol 1988;19:1053-9.
13. Tsujimoto T, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;288:1440-3.
14. Ngan BY, Chen-Levy Z, Weiss LM, Warnke RA, Cleary ML. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14:18) chromosomal translocation. N Engl J Med 1988;318:1638-44.
15. Rowley JD. Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14:18 translocation. J Clin Oncol 1988;6:919-25.
16. Lambrechts AC, Hupkes PE, Dorssers LC, van't Veer MB. Translocation (14;18)-positive cells are present in the circulation of the majority of pa-tients with localized (stage I and II) follicular non-Hodgkin's lymphoma. Blood 1993;82:2510-6.
17. Freedman AS, Munro JM, Morimoto C, Mcintyre BW, Rhynhart K, Lee N, et al. Follicular non-Hodgkin's lymphoma cell adhesion to normal germinal centers and neoplastic follicles involves very late antigen-4 and vascular cell adhesion molecule-1. Blood 1992;79:206-12.
18. Koopman G, Parmentier HK, Schuurman HJ, Newman W, Meijer CJ, Pals ST. Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways. J Exp Med 1991;173:1297-304.
19. Kim CH, Broxmeyer HE. Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol 1999;65: 6-15.
20. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998;391:799-803.
21. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 1998;187:655-60.
22. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci U S A 1998;95:258-63.
23. Ngo VN, Tang HL, Cyster JG. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J Exp Med 1998;188: 181-91.
24. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor-1 (SDF-1). J Exp Med 1996;184:1101-9.
25. Nagasawa T, Kikutani Y, Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci U S A 1994;91: 2305-9.
26. Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 1995;28:495-500.
27. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996;382:635-8.
28. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A 1998;95:9448-53.
29. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997;185:111-20.
30. Sozzani S, Luini W, Borsatti A, Polentarutti N, Zhou D, Piemonti L. et al. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol 1997;159:1993-2000.
31. Hamada T, Mohle R, Hesselgesser J, Hoxie J, Nachman RL, Moore MA. et al. Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med 1998; 188:539-48.
32. Bleul CC, Schultze JL, Springer TA. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J Exp Med 1998;187:753-62.
33. Vicente-Manzanares M, Montoya MC, Mellado M, Frade JM, del Pozo MA, Nieto M, et al. The chemokine SDF-1 α triggers a chemotactic response and induces cell polarization in human B lymphocytes. Eur J Immunol 1998;28:2197-207.
34. D'Apuzzo M, Rolink A, Loetscher M, Hoxie JA. Clark-Lewis I, Melchers F, et al. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur J Immunol 1997;27:1788-93.
35. Goffinet DR, Warnke R, Dunnick NR, Castellino R, Glatstein E, Nelsen TS, et al. Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas. Cancer Treat Rep 1977;61:981-92.
36. Corcione A, Baldi L, Zupo S, Dono M, Rinaldi GB, Roncella S, et al. Spontaneous production of granulocyte colony-stimulating factor in vitro by human B-lineage lymphocytes is a distinctive marker of germinal center cells. J Immunol 1994;153:2868-77.
37. Zigmond SH, Hirsch JG. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med 1973;137:387-410.
38. Corcione A, Ottonello L, Tortolina G, Tasso P, Ghiotto F, Airoldi I, et al. Recombinant tumor necrosis factor enhances the locomotion of memory and naive B lymphocytes from human tonsils through the selective engagement of the type II receptor. Blood 1997;90:4493-501.
39. Komai-Koma M, Liew FY, Wilkinson PC. Interactions between IL-4, anti-CD40, and anti-immunoglobulin as activators of locomotion of human B cells. J Immunol 1995;155:1110-6.
40. Serrano D, Ghiotto F, Roncella S, Airoldi I, Cutrona G, Truini M, et al. The patterns of IL2, IFN-γ, IL4 and IL5 gene expression in Hodgkin's disease and reactive lymph nodes are similar. Haematologica 1997;82:542-9.
41. Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan IC. Mechanism of antigen-driven selection in germinal centres. Nature 1989; 342:929-31.
42. Banchereau J, De Paoli P, Valle A, Garcia E, Rousset F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 1991;251:70-2.
43. Pistoia V. Production of cytokines by human B cells in health and disease. Immunol Today 1997;18:343-50.
44. Ottonello L, Corcione A, Tortolina G, Airoldi I, Albesiano E, Favre A. rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues. J Immunol 1999;162:6510-7.
45. Wilkinson PC, Islam LN. Recombinant IL-4 and IFN-γ activate locomotor capacity in human B lymphocytes. Immunology 1989;67:237-43.
46. Burthem J, Baker PK, Hunt JA, Cawley JC. The function of c-fms in hairy-cell leukemia: macrophage colony-stimulating factor stimulates hairy-cell movement. Blood 1994;83:1381-9.
47. Trentin L, Agostini C, Facco M, Piazza F, Perin A, Siviero M, et al. The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. J Clin Invest 1999;104:115-21.
48. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A 1991;88:6961-5.
49. Ghia P, Boussiotis VA, Schultze JL, Cardoso AA, Dorfman DM, Gribben JG, et al. Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival. Blood 1998;91:244-51.
50. Tuscano JM, Druey KM, Riva A, Pena J, Thompson CB, Kehrl JH. Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center. Blood 1996;88:1359-64.
51. Holder MJ, Wang H, Casamayor M, Armitage R, Spriggs MK, Fanslow WC, et al. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur J Immunol 1993;23:2368-71.
52. Leanderson T, Kallberg E, Gray D. Expansion, selection and mutation of antigen-specific B cells in germinal centers. Immunol Rev 1992;126: 47-61.
53. MacLennan IC. Germinal centers. Annu Rev Immunol 1994;12:117-39.
54. Liu YJ, Banchereau YJ. The paths and molecular controls of peripheral B-cell development. The Immunologist 1996;4:55-66.
55. rd series. Washington (DC): Armed Forces Institute of Pathology; 1995.
56. Gretz JE, Anderson AO, Shaw S. Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol Rev 1997;156:11-24.
57. McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991;349:254-6.
58. Limpens J, de Jong D, van Krieken JH, Price CG, Young BD, van Ommen GJ. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 1991;6:2271-6.
59. Limpens J, Stad R, Vos C, de Vlaam C, de Jong D, van Ommen GJ, et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 1995;85:2528-36.